China released the 10th edition of the COVID-19 diagnosis and treatment protocol on Friday.
The new protocol, jointly issued by the National Health Commission and the National Administration for Traditional Chinese Medicine, changed the Chinese term for COVID-19 from “novel coronavirus pneumonia” to “novel coronavirus infection.”
The protocol no longer requires the identification of suspicious cases, optimizes clinical classification, improves treatment methods and adjusts hospital discharge standards.
According to the protocol, people infected with the virus can stay at home or seek treatment at medical facilities. The quarantine of positive cases in designated places no longer applies in the new protocol.
The protocol streamlines treatment methods targeting the COVID-19 variants currently prevalent in China. Anti-COVID-19 drugs approved by Chinese authorities for marketing are included in the new protocol.
Emphasize the philosophy of joint treatment of COVID-19 infection and underlying health conditions, and improve the content on the use of traditional Chinese medicine in the treatment of disease.
The protocol does not require a nucleic acid test result when the patient recovers and leaves the hospital.
ODA
